IIM
CGON icon

INTECH Investment Management’s CG Oncology CGON Stock Holding History

INTECH Investment Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Sell
16,212
-273
-2% -$17.8K 0.01% 962
2026
Q1 		$1.12M Sell
16,485
-6,533
-28% -$370K 0.01% 966
2025
Q4 		$956K Buy
23,018
+9,186
+66% +$380K 0.01% 1161
2025
Q3 		$557K Sell
13,832
-15,227
-52% -$443K 0.01% 1517
2025
Q2 		$756K Buy
29,059
+6,503
+29% +$157K 0.01% 1373
2025
Q1 		$552K Buy
22,556
+5,769
+34% +$162K 0.01% 1557
2024
Q4 		$481K Buy
+16,787
New +$574K ﹤0.01% 1588

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

INTECH Investment Management's CGON Position: Q2 2026 in Review

INTECH Investment Management reduced its CG Oncology (CGON) stake by 1.7% in Q2 2026, selling an estimated $17.8K and leaving 16,212 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #962.

INTECH Investment Management first reported a position in CGON in Q4 2024 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • INTECH Investment Management held 16,212 shares of CG Oncology worth $1.15M as of Q2 2026.
  • INTECH Investment Management sold 273 CG Oncology shares in Q2 2026, an estimated $17.8K.
  • CG Oncology made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #962 holding.
  • INTECH Investment Management first reported a position in CG Oncology in Q4 2024 and has held it in 7 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.